Trials / Unknown
UnknownNCT04147975
Assessment of Assay for Rapid Identification of Bloodstream Infections From Whole Blood
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 225 (estimated)
- Sponsor
- HelixBind, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the effectiveness of RaPID/BSI by testing its performance compared to blood cultures collected prospectively from consented subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | RaPID/BSI Test | RaPID/BSI Test |
Timeline
- Start date
- 2019-10-01
- Primary completion
- 2020-09-30
- Completion
- 2020-10-30
- First posted
- 2019-11-01
- Last updated
- 2019-11-01
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04147975. Inclusion in this directory is not an endorsement.